These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 20047612

  • 1. Panel reactive HLA antibodies, soluble CD30 levels, and acute rejection six months following renal transplant.
    Domingues EM, Matuck T, Graciano ML, Souza E, Rioja S, Falci MC, Monteiro de Carvalho DB, Porto LC.
    Clin Transplant; 2010; 24(6):821-9. PubMed ID: 20047612
    [Abstract] [Full Text] [Related]

  • 2. Soluble CD30 concentrations in ESRD patients with and without panel reactive HLA antibodies.
    Vaidya S, Partlow D, Barnes T, Thomas P, Gugliuzza K.
    Clin Transplant; 2006; 20(4):461-4. PubMed ID: 16842522
    [Abstract] [Full Text] [Related]

  • 3. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G, Furst D, Mytilineos J, Pourmand G, Amirzargar AA.
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [Abstract] [Full Text] [Related]

  • 4. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
    Slavcev A, Lácha J, Honsová E, Sajdlová H, Lodererová A, Vitko S, Skibová J, Striz I.
    Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302
    [Abstract] [Full Text] [Related]

  • 5. Soluble CD30 and Cd27 levels in patients undergoing HLA antibody-incompatible renal transplantation.
    Hamer R, Roche L, Smillie D, Harmer A, Mitchell D, Molostvov G, Lam FT, Kashi H, Tan LC, Imray C, Fletcher S, Briggs D, Lowe D, Zehnder D, Higgins R.
    Transpl Immunol; 2010 Aug; 23(4):161-5. PubMed ID: 20600903
    [Abstract] [Full Text] [Related]

  • 6. Pretransplant soluble CD30 is a better predictor of posttransplant development of donor-specific antibodies and acute vascular rejection than panel reactive antibodies.
    Vaidya S, Partlow D, Barnes T, Gugliuzza K.
    Transplantation; 2006 Dec 27; 82(12):1606-9. PubMed ID: 17198244
    [Abstract] [Full Text] [Related]

  • 7. Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft.
    Pavlova Y, Viklicky O, Slatinska J, Bürgelova M, Süsal C, Skibova J, Honsová E, Striz I, Kolesar L, Slavcev A.
    Transpl Immunol; 2011 Jul 27; 25(1):72-6. PubMed ID: 21376809
    [Abstract] [Full Text] [Related]

  • 8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 9. Early post-transplant immune monitoring can predict long-term kidney graft survival: soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies.
    Amirzargar MA, Amirzargar A, Basiri A, Hajilooi M, Roshanaei G, Rajabi G, Mohammadiazar S, Solgi G.
    Hum Immunol; 2014 Jan 20; 75(1):47-58. PubMed ID: 24055694
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations.
    Cinti P, Pretagostini R, Arpino A, Tamburro ML, Mengasini S, Lattanzi R, De Simone P, Berloco P, Molajoni ER.
    Transplantation; 2005 May 15; 79(9):1154-6. PubMed ID: 15880060
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations.
    Cinti P, Pretagostini R, Arpino A, Tamburro ML, Mengasini S, Lattanzi R, De Simone P, Berloco P, Molajoni ER.
    Transplantation; 2005 Mar 15; 79(5):599-601. PubMed ID: 15753850
    [Abstract] [Full Text] [Related]

  • 12. Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy.
    Grenzi PC, Campos ÉF, Tedesco-Silva H, Felipe CR, Franco MF, Soares MF, Medina-Pestana JO, Gerbase-Delima M.
    Transpl Immunol; 2013 Dec 15; 29(1-4):34-8. PubMed ID: 23928467
    [Abstract] [Full Text] [Related]

  • 13. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K, Abbasi MA, Farokhi B, Abbasi A, Fallah P, Seifee MH, Ghadimi N, Rezaie AR.
    Exp Clin Transplant; 2009 Dec 15; 7(4):237-40. PubMed ID: 20353374
    [Abstract] [Full Text] [Related]

  • 14. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM, París SC, Arbeláez M, Cotes JM, Süsal C, Torres Y, García LF.
    Hum Immunol; 2007 Aug 15; 68(8):652-60. PubMed ID: 17678719
    [Abstract] [Full Text] [Related]

  • 15. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
    Ayed K, Abdallah TB, Bardi R, Abderrahim E, Kheder A.
    Transplant Proc; 2006 Sep 15; 38(7):2300-2. PubMed ID: 16980071
    [Abstract] [Full Text] [Related]

  • 16. Soluble CD30 and ELISA-detected human leukocyte antigen antibodies for the prediction of acute rejection in pediatric renal transplant recipients.
    Billing H, Sander A, Süsal C, Ovens J, Feneberg R, Höcker B, Vondrak K, Grenda R, Friman S, Milford DV, Lucan M, Opelz G, Tönshoff B.
    Transpl Int; 2013 Mar 15; 26(3):331-8. PubMed ID: 23279372
    [Abstract] [Full Text] [Related]

  • 17. Relation between pretransplant serum levels of soluble CD30 and acute rejection during the first 6 months after a kidney transplant.
    Shooshtarizadeh T, Mohammadali A, Ossareh S, Ataipour Y.
    Exp Clin Transplant; 2013 Jun 15; 11(3):229-33. PubMed ID: 23477385
    [Abstract] [Full Text] [Related]

  • 18. Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients.
    Wang D, Wu WZ, Chen JH, Yang SL, Wang QH, Zeng ZX, Tan JM.
    Transpl Immunol; 2010 Feb 15; 22(3-4):115-20. PubMed ID: 20036333
    [Abstract] [Full Text] [Related]

  • 19. Predicting renal graft failure by sCD30 levels and de novo HLA antibodies at 1year post-transplantation.
    Wang D, Wu G, Chen J, Yu Z, Wu W, Yang S, Tan J.
    Transpl Immunol; 2012 Jun 15; 26(4):235-9. PubMed ID: 22446727
    [Abstract] [Full Text] [Related]

  • 20. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection.
    Wang D, Wu GJ, Wu WZ, Yang SL, Chen JH, Wang H, Lin WH, Wang QH, Zeng ZX, Tan JM.
    Transpl Immunol; 2007 Jun 15; 17(4):278-82. PubMed ID: 17493531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.